Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI

Pfizer Inks Real-World Oncology Data Collaboration With Concerto HealthAI

Who’s the Boss? Companies and Their Novel Drug Approvals, 2014-2018

Who’s the Boss? Companies and Their Novel Drug Approvals, 2014-2018